Low Prevalence of Late Myocardial Injury on Cardiac MRI Following COVID-19 Infection

Ady Orbach1, Nilesh R Ghugre1,2,3, Labonny Biswas1

  • 1Schulich Heart Program, Sunnybrook Health Science Center, Toronto, Ontario, Canada.

Abstract

Insights

Cardiac MRI studies reveal a low prevalence of myocardial injury in patients after COVID-19 recovery. These findings suggest that significant heart damage is uncommon following coronavirus disease 2019 (COVID-19) infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • The prevalence of cardiac magnetic resonance imaging (MRI) findings indicating myocardial injury post-coronavirus disease 2019 (COVID-19) recovery remains uncertain.
  • Previous reports show high variability in the prevalence of such findings.

Purpose of the Study:

  • To determine the prevalence of myocardial injury in patients following COVID-19 infection using cardiac MRI.
  • To assess cardiac function and myocardial tissue characteristics after COVID-19.

Main Methods:

  • A prospective, bicentric study involving 70 COVID-19 recovered patients, 10 healthy controls, and 75 nonischemic cardiomyopathy patients.
  • Cardiac MRI sequences including steady-state free precession (SSFP), T1/T2 mapping, and late gadolinium enhancement (LGE) were acquired approximately 4-5 months post-infection.
  • Analysis included ventricular volumes, ejection fractions, T1/T2 values, and LGE assessment, with statistical comparisons between groups.

Main Results:

  • Reduced right ventricular ejection fraction (RVEF) was observed in 10% of COVID-19 patients, while elevated native T1 and LGE were present in 9%.
  • Reduced left ventricular ejection fraction (LVEF) occurred in 4%, and elevated T2 in 3% of post-COVID-19 patients.
  • Nonischemic cardiomyopathy patients exhibited significantly lower LVEF and RVEF, and a higher prevalence of LGE compared to the COVID-19 group.

Conclusions:

  • Abnormal cardiac MRI findings indicative of myocardial injury appear to have a low prevalence in patients hospitalized and recovered from COVID-19.
  • The study suggests that significant cardiac damage is not a common long-term consequence of COVID-19 hospitalization.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
16
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
11
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
71
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
54
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
18